Cincinnati Academics Contribute To New Antiepileptic Drug Handbook
CINCINNATISix University of Cincinnati (UC) faculty members have coauthored a new handbook for physicians titled Clinicians Guide to Antiepileptic Drug Use.
According to Michael Privitera, MD, the handbook and PDA reference, published by Lippincott, Williams & Wilkins, is the first reference of its kind for the different specialties that use antiepileptic medications for seizure control and non-seizure indications like pain, headache and psychiatric disorders.
Designed as a quick point-of-care reference, it provides guidelines on use of antiepileptic drugs for treatment of seizures, psychiatric disorders, pain and headache.
The other UC authors are Jennifer Cavitt, MD, David Ficker, MD, and Jerzy Szaflarski, MD, PhD, all from the department of neurology and the Neuroscience Institute, Marcia Kaplan, MD, psychiatry, and visiting faculty member Timothy Welty, PharmD.
For more information call Chris Gates, call (513) 558-5440.
Tags
Related Stories
UC radiation oncologist speaks with Local 12 news about clinical trial for head and neck cancer treatment
August 10, 2026
Dr. Sara Medek, a UC radiation oncology professor, speaks with Local 12 news about a new clinical trial aimed at reducing radiation in certain areas while still treating cancer effectively but with fewer painful side effects.
Cancer Center director charts future based on collaboration, AI
August 10, 2026
David Gius, MD, PhD, was featured in a Cincinnati Business Courier article and The Cancer Letter’s “The Directors" podcast discussing his priorities and goals as he recently took the helm as director of the University of Cincinnati Cancer Center.
Bidirectional link between oral, kidney health calls for patient education, access
August 4, 2026
Despite growing awareness of the connection between oral health and chronic health conditions, patient awareness and access to dental care remain limited, according to University of Cincinnati experts who recently spoke with Healio | Nephrology News & Issues.